chr9-132910483-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000493467.6(TSC1):​n.622A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00357 in 1,606,576 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 12 hom. )

Consequence

TSC1
ENST00000493467.6 non_coding_transcript_exon

Scores

7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:3

Conservation

PhyloP100: -1.25

Publications

2 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005337715).
BP6
Variant 9-132910483-T-C is Benign according to our data. Variant chr9-132910483-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 41689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0024 (366/152356) while in subpopulation NFE AF = 0.00438 (298/68046). AF 95% confidence interval is 0.00397. There are 1 homozygotes in GnomAd4. There are 169 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 366 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC1NM_000368.5 linkc.1263+88A>G intron_variant Intron 12 of 22 ENST00000298552.9 NP_000359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC1ENST00000298552.9 linkc.1263+88A>G intron_variant Intron 12 of 22 1 NM_000368.5 ENSP00000298552.3
TSC1ENST00000490179.4 linkc.1263+88A>G intron_variant Intron 13 of 23 3 ENSP00000495533.2

Frequencies

GnomAD3 genomes
AF:
0.00240
AC:
366
AN:
152238
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00438
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00236
AC:
588
AN:
248920
AF XY:
0.00242
show subpopulations
Gnomad AFR exome
AF:
0.000688
Gnomad AMR exome
AF:
0.000579
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00149
Gnomad NFE exome
AF:
0.00427
Gnomad OTH exome
AF:
0.00246
GnomAD4 exome
AF:
0.00369
AC:
5368
AN:
1454220
Hom.:
12
Cov.:
31
AF XY:
0.00356
AC XY:
2580
AN XY:
723746
show subpopulations
African (AFR)
AF:
0.000570
AC:
19
AN:
33334
American (AMR)
AF:
0.000581
AC:
26
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.000999
AC:
86
AN:
86088
European-Finnish (FIN)
AF:
0.00145
AC:
76
AN:
52580
Middle Eastern (MID)
AF:
0.000869
AC:
5
AN:
5754
European-Non Finnish (NFE)
AF:
0.00450
AC:
4975
AN:
1105830
Other (OTH)
AF:
0.00291
AC:
175
AN:
60174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
303
606
910
1213
1516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00240
AC:
366
AN:
152356
Hom.:
1
Cov.:
32
AF XY:
0.00227
AC XY:
169
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.000577
AC:
24
AN:
41568
American (AMR)
AF:
0.000392
AC:
6
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00438
AC:
298
AN:
68046
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00277
Hom.:
0
Bravo
AF:
0.00221
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00363
AC:
14
ExAC
AF:
0.00233
AC:
283

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3Other:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TSC1: BS2 -

Jul 13, 2012
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research

- -

Tuberous sclerosis syndrome Other:2
-
Tuberous sclerosis database (TSC1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

-
Tuberous sclerosis database (TSC1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.23
DANN
Benign
0.58
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.31
.;.;T;T
MetaRNN
Benign
0.0053
T;T;T;T
PhyloP100
-1.3
Polyphen
0.0
B;B;B;.
GERP RS
-2.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118203507; hg19: chr9-135785870; COSMIC: COSV104404440; API